Neem Tree (Azadirachta indica): A Comprehensive Reference
1. Identity and Botanical Classification
Scientific Name and Taxonomy
Azadirachta indica, commonly known as neem, margosa, nimtree, or Indian lilac, is a tree in the mahogany family Meliaceae. It is one of the two species in the genus Azadirachta, native to the Indian subcontinent and to parts of Southeast Asia. The name Azadirachta indica was first published by Adrien-Henri de Jussieu in 1830, who considered what Linnaeus in 1753 had called Melia azadirachta sufficiently different from Melia azedarach to be placed in a new genus.
The term "Azadirachta" is derived from the Persian Azad-darkht, meaning "great tree," and indica indicates an Indian origin. The common name "nim" is a Hindustani noun derived from Sanskrit nimba (निंब). The plant is also known by many other names: Nimba, Nimb, Indian Lilac, Bead Tree, Holy Tree, Margosa Tree, Nim, Persian Lilac, Pride of China, Ravipriya, and Veppu.
Morphology and Distribution
The neem tree is fast-growing, reaching a height of 15–20 metres (49–66 ft), rarely 35–40 m (115–131 ft); it is evergreen, shedding many of its leaves during dry winter months, with wide, spreading branches. The fairly dense, roundish crown may reach a diameter of 20–25 m; the opposite, pinnate leaves are 20–40 cm long, with 20 to 30 medium to dark green leaflets about 3–8 cm long. Its fruits are green drupes, which turn golden yellow upon ripening in the months of June–August.
The species is native to the Indian subcontinent and parts of Southeast Asia but is naturalized and grown around the world in tropical and subtropical areas. It is found in the Western Himalayas of India and in Iran, and is cultivated in other parts of India and the tropical regions of the world such as Indonesia, Australia, and West Africa. Its fruits and seeds are the primary source of neem oil.
Plant Parts Used and Common Preparations
Almost every part of the neem tree is used in traditional medicine (e.g., Ayurveda, Unani, Siddha, Amchi) in many countries, with some 700 preparations described. The leaves, seeds, blossoms, and bark are widely used for various applications. Neem is commonly sold in oil, extract, powder, and supplement forms, as well as added to hair, skin, and oral care products.
- Neem oil: Derived from the fruits and seeds. Used topically for skin and hair, and historically consumed orally in parts of Asia.
- Leaf preparations: Fresh juice, aqueous decoctions, dried leaf powder, and standardized extracts are the most studied forms.
- Bark extracts: The root and bark are described as antiperiodic, astringent, and tonic; the bark specifically is also astringent, antiviral, bitter, tonic, and vermifuge.
- Dental preparations: Twigs of the plant have been used historically as toothbrushes.
- Capsules/tablets: Commercially available as standardized leaf or bark extract capsules.
- Mouthwash and dental gel: Aqueous neem extracts formulated as mouthrinses and dental gels used in oral hygiene studies.
2. Traditional and Historical Use
Antiquity and Pre-written Records
Neem has been used extensively by humankind to treat various ailments before the availability of written records; its use by humankind dates to prehistoric times. Surpassing 6,500 well-documented medicinal plants, India holds a treasure house of knowledge in this regard, and neem is one of the most important medicinal plants widely used by all medicinal systems.
Ayurvedic Tradition
Ancient Indian medical literature, one of the world's most well-documented knowledge systems dating back between 1500 BCE and 1900 CE, contains detailed theoretical foundations and resources from Ayurveda, Unani, Siddha, and Tibetan medicine on medicinal plants, disease diagnosis, and treatment methods.
Neem has been widely used in Chinese, Ayurvedic, and Unani medicines worldwide, especially in the Indian subcontinent, in the treatment and prevention of various diseases. In Ayurveda, neem is known as "Sarva Roga Nivarini" — the healer of all diseases. In Ayurveda, neem is classed as tikta (bitter) and kashaya (astringent), cooling in nature, and is grouped with the Kapha- and Pitta-settling herbs.
The Bhavaprakasha Nighantu places Nimba in the Guduchyadi Varga and describes it as Kushtaghna (for the skin), Kandughna (for itching), and Krimighna (against micro-organisms). Classical Ayurvedic texts describe numerous preparations and purposes:
- Traditionally, neem leaves, flowers, seeds, fruits, roots, twigs, and bark have been used to treat fever, infection, skin conditions, and dental problems.
- The flowers of Azadirachta indica are described as stimulant, stomachic, and tonic; the fruit as anthelmintic, purgative, and emollient; and the juice as anthelmintic.
- Ancient healers used neem leaves, bark, and oil to treat fevers, infections, digestive disorders, and joint pain.
Unani and Other Medical Traditions
Neem has been widely utilized in Ayurveda, Unani, and Homeopathic treatments and has gained significant attention in modern medicine. Neem has been used for centuries in traditional medicine for the treatment of various conditions including fevers, infections, and inflammations; due to its extensive use in rural regions for the treatment of a variety of medical conditions, it is also referred to as the "village pharmacy."
3. Key Constituents and Active Compounds
Chemical Classification
Neem compounds can be classified into two major sections: isoprenoids and non-isoprenoids. Isoprenoids are classified into diterpenoids and triterpenoids. Numerous phytochemicals have been isolated from different parts of the plant, including triterpenes, gallic acid, nimbins, saponins, catechins, limonoids, flavonoids, phenols, and glycoproteins.
Principal Bioactive Compounds
Azadirachtin is the most important active constituent. Other compounds present in leaves include sodium nimbinate, nimbidol, nimbin, nimbolinin, nimbidin, gedunin, salannin, quercetin, ascorbic acid, n-hexacosanol, amino acids, 6-desacetylnimbinene, nimbandiol, nimbolide, 7-desacetyl-7-benzoylazadiradione, 7-desacetyl-7-benzoylgedunin, 17-hydroxyazadiradione, and nimbiol. Gedunin and azadirachtin are two important components of neem seeds.
Quercetin and β-sitosterol, polyphenolic flavonoids, were purified from neem fresh leaves and were known to have antibacterial and antifungal properties; seeds hold valuable constituents including gedunin and azadirachtin.
Key compounds and their documented biological roles, as identified in peer-reviewed literature, include:
- Azadirachtin: The most active compound of neem, and toxic to insects. The terpenoid chief constituent of neem, mainly responsible for the antibacterial properties of neem.
- Nimbidin: A principle component of neem, responsible for its antibacterial and anti-inflammatory action.
- Nimbolide: Along with azadirachtin and gedunin, nimbolide is reported to have a tremendous ability to regulate numerous biological processes in vitro and in vivo.
- Gedunin: Identified with anti-malarial and anti-fungal properties in laboratory analyses.
- Nimbin: Associated with anti-inflammatory properties. In 1942, Siddiqui isolated the first bitter compound nimbin from neem seed; nimbin itself is an inactive compound, but it can be changed into salannin due to enzymatic reaction.
- Sodium nimbinate: Described in the literature as having diuretic and anti-arthritic properties.
- Salannin: Identified as a repellent compound.
- Quercetin and β-sitosterol: Polyphenolic flavonoids recognized to have antifungal and antibacterial properties, isolated from fresh neem leaves.
Mechanisms of Action
Earlier findings confirmed that neem and its constituents play a role in the scavenging of free radical generation and prevention of disease pathogenesis. Accumulating evidence demonstrates that these compounds have been studied for their potent antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory properties.
The following mechanisms have been identified through laboratory and animal research:
- Anti-inflammatory pathway: Neem plays a role as an anti-inflammatory agent via regulation of proinflammatory enzyme activities including cyclooxygenase. Neem components have also been shown to inhibit NF-κB activation, reducing inflammation at the molecular level.
- Antimicrobial mechanisms: Neem's potent antibacterial, antifungal, and antiviral properties are due to its diverse array of phytochemicals, including limonoids (azadirachtin, nimbin, nimbidin), flavonoids (quercetin, kaempferol), tannins, and triterpenoids. These compounds act by disrupting microbial cell membranes, inhibiting vital metabolic enzymes, preventing biofilm formation, and inducing oxidative stress in pathogens.
- Antioxidant activity: Azadirachtin and nimbolide showed concentration-dependent antiradical scavenging activity and reductive potential in the following order: nimbolide > azadirachtin > ascorbate.
- Anticancer pathways (preclinical): Studies based on animal models established that neem and its chief constituents play a pivotal role in anticancer management through the modulation of various molecular pathways including p53, pTEN, NF-κB, PI3K/Akt, Bcl-2, and VEGF.
- Dental antibiofilm: Neem extract inhibited insoluble glucan synthesis, thereby reducing the adherence of streptococci to tooth surfaces. Polyphenolic tannins present in the extract effectively bind to surface-associated bacterial proteins, resulting in bacterial aggregation and loss of glucosyltransferase activity.
4. Scientific Evidence by Area of Use
4.1 Oral Health (Dental Plaque and Gingivitis)
Oral health is the area with the most consistently studied human clinical evidence for neem.
In recent years, neem has been evaluated for its crucial role in oral health, displaying comparable efficacy in reducing plaque, gingivitis, and cariogenic bacteria.
A clinical study of six weeks was conducted to check the efficacy of a neem extract dental gel compared with chlorhexidine gluconate (0.2% w/v) mouthwash as positive control; results showed that the dental gel containing neem extract significantly reduced the plaque index and bacterial count compared to the control group.
In a registered randomized, double-blind, parallel-armed, controlled trial, 60 participants were randomly allocated into two groups of 30 each: Group A receiving 2.5% neem gel, and Group B receiving 0.2% chlorhexidine (CHX) gel. In that study, neem gel showed anti-plaque and anti-gingivitis effects comparable to CHX gel.
A randomized, double-blind clinical trial enrolled 30 first-year dental students who used neem-containing toothpaste as the intervention; clinical examination was carried out using Silness and Loe plaque index (PI) and Loe and Silness gingival index (GI). A statistically significant difference was found between the test and control group after intervention with respect to both the PI and GI.
A randomized, double-blind clinical trial compared a herbal dentifrice containing neem, clove, and tea tree oil against a conventional fluoride dentifrice and placebo in 90 participants with mild gingivitis, recording Plaque Index (PI) and Gingival Index (GI) at baseline, 2 weeks, and 4 weeks. At 4 weeks, the herbal dentifrice showed the greatest reductions in PI (60.7%) and GI (55.7%) compared to fluoride (48.6%, 41.8%) and placebo (21.4%, 13.2%), with significant intergroup differences (p < 0.001). However, this trial used a multi-ingredient formulation, making it impossible to isolate neem's independent contribution.
Not all evidence is uniformly positive: while neem may reduce the number of bacteria in the mouth that can cause plaque, using a mouthrinse containing neem extract for 2 weeks does not appear to reduce plaque or gingivitis in some trials. Overall, the oral health evidence is among the strongest for neem in human studies, though study populations are typically small.
4.2 Glycemic Control and Type 2 Diabetes
The antidiabetic potential of neem has been explored in both preclinical and a small number of human clinical studies.
A randomized, double-blind, placebo-controlled clinical study (RCT) was aimed at evaluating the safety and efficacy of a standardized aqueous extract of Azadirachta indica leaves and twigs (NEEM) on glycemic control, endothelial dysfunction, and systemic inflammation in patients with T2DM. In this RCT, 80 T2DM subjects already on standard metformin therapy received either 125 mg, 250 mg, or 500 mg of NEEM or placebo twice daily for 12 weeks. Postprandial blood sugar level (PPBS), fasting blood sugar level (FBS), glycosylated hemoglobin (HbA1c), insulin resistance (IR), endothelial function, oxidative stress, systemic inflammation, IL-6 and TNF-α, platelet aggregation, and lipid profile were assessed.
The study concluded that NEEM may significantly ameliorate hyperglycemia, endothelial dysfunction, and systemic inflammation, on top of what metformin could do, in subjects with T2DM. However, important limitations were noted: animal study results may not always hold true in controlled human clinical trials, as NEEM in this study showed no effect on lipid profile, while some animal studies have shown improvement.
Most other evidence for antidiabetic effects remains preclinical. A study evaluating a 70% alcoholic neem root bark extract in diabetes showed statistically significant results at an 800 mg/kg dose (an animal study). Another animal experiment showed that neem extract at 250 mg/kg demonstrated significantly reduced glucose levels compared to control group in diabetic rats. A substantial amount of research has been done on regulation of blood glucose level using A. indica extracts and compounds, with little information on individual phytochemicals. The overall human evidence base for diabetes management remains limited and preliminary.
4.3 Skin Conditions
A double-blind clinical drug trial was performed to check the efficacy of a drug made from aqueous extract of neem leaves in 50 cases of uncomplicated psoriasis taking conventional coal tar regime; results revealed that patients taking the drug in addition to coal tar showed a quicker and better response in comparison to the placebo group.
Early research suggests that taking neem extract by mouth for 12 weeks, along with daily sun exposure and the application of a coal tar and salicylic acid cream, reduces the severity of psoriasis symptoms. This evidence is preliminary, based on small trials with multiple co-interventions, making attribution to neem alone difficult.
4.4 Gastrointestinal Conditions (Ulcers)
Some research suggests that taking 30–60 mg of neem bark extract twice daily by mouth for 10 weeks helps heal stomach and intestinal ulcers. This claim is based on early research, and larger, rigorously controlled trials are lacking.
4.5 Antimicrobial and Antifungal Activity
Laboratory evidence for neem's antimicrobial properties is extensive, though human clinical data remain limited.
In laboratory studies, neem preparations showed toxicity to cultures of 14 common fungi, including members of the genera Trichophyton, Epidermophyton, Microsporum, Geotrichum, and Candida. In trials, neem oil has suppressed several species of pathogenic bacteria, including Staphylococcus aureus.
Neem extracts have shown promising inhibition against several microbial strains in vitro, including Candida albicans, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Neem has been proven to have immunomodulatory, anti-inflammatory, antihyperglycaemic, antiulcer, antimalarial, antifungal, antibacterial, antioxidant, as well as anticarcinogenic properties — though it must be noted that the majority of these findings are from laboratory or animal studies, not controlled human trials.
4.6 Anticancer Research (Preclinical Only)
Reports exist of the use of neem seed oil in individual patients with epidermal cancer and parotid tumor, but clinical outcome measures were not adequately reported. Human cancer cell line studies include antiandrogenic effects against prostate cancer cells, induction of oral squamous cell cancer apoptosis, and cytotoxic effects on breast cancer cells. Nimbolide extracted from neem flowers interfered with the cell cycle of leukemic and melanoma cell lines and induced apoptosis. All cancer-related evidence remains at the preclinical (cell line and animal) stage; no controlled human clinical trials have established neem as an effective anticancer agent.
4.7 Hepatoprotective Effects
A study evaluated the protective effect of the active neem constituent nimbolide against carbon tetrachloride (CCl₄)-induced liver toxicity in rats; results suggested that nimbolide possesses a hepatoprotective effect against CCl₄-induced liver damage with efficiency similar to that of silymarin standard. Another study revealed that leaf extract was found to have protection against paracetamol-induced liver necrosis in rats. These findings are animal studies; human clinical evidence for hepatoprotection is absent.
4.8 Anti-inflammatory and Cardiovascular Effects
Ethanol extracts of neem leaf induced important and dose-dependent hypotensive action in rats, but bradycardia, as well as cardiac arrhythmia, was also observed. Crude extracts of neem root and stem bark have shown diuretic and hypotensive action. Sodium nimbidinate induced diuresis in dogs. Deep intramuscular injection of sodium nimbidinate resulted in adequate diuresis in a small study of patients with congestive cardiac failure. These cardiovascular findings are based on animal models or very small, older human studies, and the arrhythmia observation warrants caution.
4.9 Insect Repellency
Early research suggests that applying extract of neem root or leaf to the skin helps repel black flies; also, applying neem oil cream to the skin seems to protect against some types of mosquitos. This application area has reasonably supportive evidence given the well-characterized insecticidal activity of azadirachtin.
5. Body Systems and Health Areas Associated with Neem
Neem demonstrates a wide range of therapeutic activities, including anti-inflammatory, anti-arthritic, antipyretic, hypoglycemic, anti-ulcer, anticancer, antidiabetic, neuroprotective, antifungal, antibacterial, and antitumor effects. The following body systems have been most studied in the scientific literature:
- Oral and dental health: Plaque, gingivitis, cariogenic bacteria, periodontal disease.
- Endocrine/metabolic: Blood glucose regulation, insulin resistance, endothelial function in type 2 diabetes.
- Skin and integumentary: Psoriasis, acne, skin infections, eczema, wound healing.
- Gastrointestinal: Peptic ulcers, intestinal worms, digestive upsets.
- Hepatic: Hepatoprotective activity studied in animal models.
- Cardiovascular: Preliminary evidence for blood pressure and diuretic effects.
- Immune: Immunomodulatory and antioxidant pathways.
- Neurological: Scientific evidence suggests it may mitigate key pathological features of Alzheimer's disease by reducing amyloid-beta plaque formation, inhibiting tau protein aggregation, and promoting synaptic plasticity; it also exhibits neuroprotective properties through the attenuation of oxidative stress and neuroinflammation. This evidence is currently limited to in silico and preclinical models.
6. Dosage Forms and Reported Dosages
No universally accepted standardized dosage has been established for neem in human medicine. The following dosages are drawn directly from sources describing specific studies or clinical contexts:
- Standardized aqueous leaf/twig extract (diabetes RCT): 125 mg, 250 mg, or 500 mg of a standardized aqueous extract, administered twice daily for 12 weeks in T2DM patients on metformin.
- Neem bark extract (ulcers): 30–60 mg of neem bark extract twice daily by mouth for 10 weeks, as reported in early research on gastric and intestinal ulcers.
- Dental gel: 2.5% neem gel, used as a topical oral application in a double-blind RCT.
- Mouthrinse: 0.19% Azadirachta indica mouthrinse used in a clinical trial for plaque-induced gingivitis.
- Neem oil (estimated safe dose, animal-based): Based on animal studies, an estimated safe dose of neem oil of 0.2 mL/kg has been suggested in adults.
- Sodium nimbidinate (historical cardiac study): Deep IM injections of sodium nimbidinate 250 mg daily have been used in a trial in congestive cardiac failure.
Neem tree (Azadirachta indica) offers different bioactives ranging from pesticides to therapeutic molecules, depending on which part of the plant is used and the extraction methodology and the solvent used. This variability makes cross-study dosage comparison difficult.
7. Safety Considerations
General Adult Safety
No hazard has been observed when neem has been used in topical treatments (on skin complaints, for example) or in dental uses — which together make up by far the major medical applications. Research reveals few or no adverse reactions in adults with the use of neem at normal doses.
Neem Oil: Serious Risks
Neem oil is of particular concern when consumed internally. Doses as small as 5 mL have killed infants, and animal studies showed acute toxicity at doses as low as 14–24 mL per kg of body weight. In a case report of a 35-year-old woman, bilateral vision loss occurred 5 days after consumption of approximately 150 mL of neem oil. The use of oral neem oil in children cannot be supported due to reported deaths.
Variability by Preparation Type
The non-aqueous extracts appear to be the most toxic neem-based products, with an estimated safe dose (ESD) of 0.002 and 12.5 microg/kg bw/day. Less toxic are the unprocessed materials — seed oil and aqueous extracts (ESD 0.26 and 0.3 mg/kg bw/day respectively). Most of the pure compounds show a relatively low toxicity (ESD azadirachtin 15 mg/kg bw/day).
Hepatotoxicity
Drug-induced liver injury has been reported in association with neem use. The leaves or leaf extracts should not be consumed by people over a long period. There are anecdotal reports of renal failure in Ghanaians who were drinking leaf teas as a malaria treatment.
Contaminants
Neem oil (made from neem seeds) contains low concentrations of aflatoxin that are poisonous in large doses.
Potential Drug Interactions
In addition to possible beneficial health effects such as blood sugar lowering properties, anti-parasitic, anti-inflammatory, anti-ulcer, and hepatoprotective effects, toxic effects are also described. The hypoglycemic activity of neem is clinically relevant when combined with antidiabetic medications, as additive blood glucose lowering could occur. No drug interactions are well documented in the formal literature, though the blood-glucose-lowering observed in human RCTs (on top of metformin) implies additive pharmacodynamic interaction with antidiabetic drugs.
Pregnancy and Lactation
Information regarding safety and efficacy in pregnancy and lactation is lacking. The leaf is also reported in traditional use for birth control and to cause abortions — these properties and the lack of safety data make neem use inadvisable in pregnancy.
Species Confusion Risk
The seeds of neem, which are poisonous in large doses, resemble the more toxic drupes of M. azedarach (chinaberry), and the two are sometimes confused.
8. Summary of Evidence Strength
- Oral health (plaque/gingivitis): Multiple small randomized controlled trials in humans; evidence is consistent and moderately supportive, particularly for neem gel, dental gel, and toothpaste formulations. Study populations are typically small.
- Glycemic control in T2DM: At least one published RCT (n=80) showing statistically significant effects; evidence is promising but preliminary — requires replication in larger, independently conducted trials.
- Gastric ulcers: Early-phase human data only; insufficient evidence for firm conclusions.
- Skin conditions (psoriasis): Small clinical trials with co-interventions; neem's independent contribution cannot be reliably isolated.
- Antimicrobial activity: Strong in vitro and animal data; human clinical evidence is largely absent.
- Anticancer, hepatoprotective, cardiovascular, neuroprotective: Predominantly in vitro (cell culture) and animal data only; no adequately powered human trials exist.
- Insect repellency: Early research supportive; well-mechanistically explained by azadirachtin's documented insecticidal activity.
References
Volver